KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Amortization - Intangibles (2020 - 2024)

Historic Amortization - Intangibles for Vir Biotechnology (VIR) over the last 5 years, with Q2 2024 value amounting to $18.8 million.

  • Vir Biotechnology's Amortization - Intangibles fell 1811.78% to $18.8 million in Q2 2024 from the same period last year, while for Jun 2024 it was $82.8 million, marking a year-over-year increase of 1857.3%. This contributed to the annual value of $87.0 million for FY2023, which is 20966.11% up from last year.
  • Per Vir Biotechnology's latest filing, its Amortization - Intangibles stood at $18.8 million for Q2 2024, which was down 1811.78% from $21.3 million recorded in Q1 2024.
  • Over the past 5 years, Vir Biotechnology's Amortization - Intangibles peaked at $23.0 million during Q2 2023, and registered a low of $11000.0 during Q3 2021.
  • Moreover, its 5-year median value for Amortization - Intangibles was $2.0 million (2020), whereas its average is $8.8 million.
  • As far as peak fluctuations go, Vir Biotechnology's Amortization - Intangibles crashed by 9733.01% in 2021, and later soared by 8473636.36% in 2022.
  • Vir Biotechnology's Amortization - Intangibles (Quarter) stood at $288000.0 in 2020, then plummeted by 42.01% to $167000.0 in 2021, then surged by 9583.83% to $16.2 million in 2022, then increased by 28.22% to $20.7 million in 2023, then dropped by 9.11% to $18.8 million in 2024.
  • Its last three reported values are $18.8 million in Q2 2024, $21.3 million for Q1 2024, and $20.7 million during Q4 2023.